A randomized, double blind, active controlled, parallel group study to evaluate the effectiveness of valsartan 320 mg in combination with lisinopril 20 mg versus monotherapy with lisinopril 40 mg or v...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000186-35

A randomized, double blind, active controlled, parallel group study to evaluate the effectiveness of valsartan 320 mg in combination with lisinopril 20 mg versus monotherapy with lisinopril 40 mg or valsartan 320 mg in hypertensive patients with microalbuminuria on reduction of urinary albumin creatinine ratio

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To demonstrate the difference in microalbuminuria (MAU) in form of urinary albumin excretion measured as urinary albumin/creatinine ratio (UACR) in the first morning urine after treatment with valsartan 320 mg/lisinopril 20 mg combination compared to lisinopril 40 mg monotherapy and to valsartan 320 mg monotherapy from baseline to Week 30 in hypertensive subjects with previously diagnosed MAU (baseline).


Critère d'inclusion

  • Adult patient with mild to moderate essential hypertension and microalbuminuria

Liens